Mediolanum International Funds Ltd increased its position in Ecolab Inc. by 14.0% during the third quarter, acquiring an additional 2,851 shares to bring its total to 23,246 shares. At period end, the stake was valued at approximately $6.34 million, reflecting the firm’s confidence in Ecolab’s water, hygiene and infection prevention franchise across hospitality, healthcare and industrial end markets.

Several large asset managers adjusted their Ecolab holdings in the same quarter. Robeco Institutional Asset Management B.V. added 344,541 shares, growing its stake by 64.5% to 878,829 shares, while Adams Diversified Equity Fund Inc. increased its stake by 25.8%, acquiring 14,800 shares to reach 72,200 shares. Mirae Asset Global Investments Co. Ltd expanded its position by 20.5% to 66,656 shares, and McKinley Carter Wealth Services Inc. more than doubled its exposure, adding 3,320 shares for a 162.4% gain to 5,364 shares. Despite these shifts, institutional investors collectively held 74.91% of the stock at quarter end.

In mid-January, Ecolab raised its quarterly dividend from $0.65 to $0.73 per share, representing an annualized payout of $2.92 and a payout ratio of 41.95%. The company’s balance sheet remains solid, with a current ratio of 1.70 and debt-to-equity ratio of 0.83. Analysts maintain a constructive stance, with one Strong Buy, ten Buy and six Hold ratings, and an average consensus P/E of 40.7 and PEG ratio of 2.44 reflecting expectations for mid-single-digit earnings growth.

Director David Maclennan purchased 750 shares at an average cost of $257.60 in early December, increasing his holdings by 3.37% to 23,035 shares. Conversely, CEO Christophe Beck trimmed his position in mid-November, selling 21,714 shares at an average of $261.41, reducing his stake by 23.01% to 72,644 shares. These moves underscore differing views among management on near-term valuation levels.